Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0MM2L
|
|||
| Former ID |
DNAP001708
|
|||
| Drug Name |
Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Approved | [1] | |
| Human immunodeficiency virus-1 infection [ICD-11: 1C62; ICD-10: B20-B24] | Phase 2 | [2] | ||
| Company |
GILEAD
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H10FN3O3S
|
|||
| Canonical SMILES |
C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
|
|||
| InChI |
1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5?,6-/m1/s1
|
|||
| InChIKey |
XQSPYNMVSIKCOC-PRJDIBJQSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Gilead. | |||
| REF 2 | ClinicalTrials.gov (NCT01565850) Safety and Efficacy of Darunavir/Cobicistat/Emtricitabine/GS-7340 Single Tablet Regimen Versus Cobicistat-boosted Darunavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate Fixed Dose Combination in HIV-1 Infected, Antiretroviral Treatment Naive Adults. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.